These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 33914089)
1. [Secondary stroke prevention after TIA or ischemic stroke]. Diener HC; Nickenig G Herz; 2021 Jun; 46(3):293-302. PubMed ID: 33914089 [TBL] [Abstract][Full Text] [Related]
2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L; JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037 [TBL] [Abstract][Full Text] [Related]
3. Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar. Diener HC; Hankey GJ J Am Coll Cardiol; 2020 Apr; 75(15):1804-1818. PubMed ID: 32299593 [TBL] [Abstract][Full Text] [Related]
4. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials. Vaduganathan M; Qamar A; Gupta A; Bajaj N; Golwala HB; Pandey A; Bhatt DL Am J Med; 2018 May; 131(5):575-577. PubMed ID: 29229471 [TBL] [Abstract][Full Text] [Related]
5. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke. Wiktor DM; Carroll JD Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380 [TBL] [Abstract][Full Text] [Related]
6. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study. Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661 [TBL] [Abstract][Full Text] [Related]
7. Adding patent foramen ovale closure to antiplatelet drugs reduced ischemic stroke after cryptogenic stroke. Alberts MJ Ann Intern Med; 2018 Jan; 168(2):JC6. PubMed ID: 29335718 [No Abstract] [Full Text] [Related]
8. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis. Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819 [TBL] [Abstract][Full Text] [Related]
9. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. Furlan AJ; Reisman M; Massaro J; Mauri L; Adams H; Albers GW; Felberg R; Herrmann H; Kar S; Landzberg M; Raizner A; Wechsler L; N Engl J Med; 2012 Mar; 366(11):991-9. PubMed ID: 22417252 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism. Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Asmarats L; Côté M; Rodés-Cabau J J Am Coll Cardiol; 2019 Jan; 73(3):278-287. PubMed ID: 30678757 [TBL] [Abstract][Full Text] [Related]
11. Management of Patients With a Patent Foramen Ovale With History of Stroke or TIA. Dia A; Cifu AS; Shah AP JAMA; 2021 Jan; 325(1):81-82. PubMed ID: 33399834 [No Abstract] [Full Text] [Related]